GGrantIndex
← Leaderboards

Jeffrey S Friedman

Dana-Farber Cancer Institute

$6,870,136
Attributed
$6,870,136
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200510
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$6,870,136 · 9

By mechanism

R01$4,166,440 · 4
M01$1,460,936 · 1
R21$795,824 · 2
K08$231,822 · 1
S10$215,114 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Proteins

Research focus

ProteinsErythrocytesAnemiaProductionPathogenesisResponsePatternBone MarrowInfectionGene ExpressionLaboratory MouseElectron MicroscopyMeasurementSamplingGenetically Modified AnimalsCharacteristicsOxidative DamageClinical ResearchLesionOxidationProteomeMolecularBlood /Lymphatic PharmacologyMitochondria

Grant awards (21)

Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics$474,750
R01 · FY2010 · DK · contact PI
Anemia in the Elderly: Pathogenesis$377,796
R01 · FY2010 · AG · contact PI
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics$474,750
R01 · FY2009 · DK · contact PI
Anemia in the Elderly: Pathogenesis$380,706
R01 · FY2009 · AG · contact PI
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell$237,375
R21 · FY2009 · DK · contact PI
Anemia in the Elderly: Pathogenesis$380,706
R01 · FY2008 · AG · contact PI
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell$279,600
R21 · FY2008 · DK · contact PI
Reactive Oxygen Species in Anti-Viral Airway Host Defense$278,849
R21 · FY2008 · AI · contact PI
Regulation of superoxide production by human neutrophils$444,933
R01 · FY2007 · AI · contact PI
Pathogenesis and Therapy of Sideroblastic Anemia$318,574
R01 · FY2007 · DK · contact PI
DIGE Package: Variable Mode Imager and Spot Picker$215,114
S10 · FY2007 · RR · contact PI
Pathogenesis and Therapy of Sideroblastic Anemia$328,088
R01 · FY2006 · DK · contact PI
LEPTIN TREATMENT FOR PREVENTION OF THE METABOLIC AND ENDOCRINE SEQUELAE$699,888
M01 · FY2005 · RR
Pathogenesis and Therapy of Sideroblastic Anemia$335,983
R01 · FY2005 · DK
Leptin Treatment for Prevention of Metabolic &Endocrine$761,048
M01 · FY2004 · RR
Pathogenesis and Therapy of Sideroblastic Anemia$335,983
R01 · FY2004 · DK
Pathogenesis and Therapy of Sideroblastic Anemia$202,729
R01 · FY2003 · DK
Pathogenesis and Therapy of Sideroblastic Anemia$69,254
R01 · FY2003 · DK
Pathogenesis and Therapy of Sideroblastic Anemia$42,188
R01 · FY2003 · DK
CYCLOPHILIN C FUNCTION$115,911
K08 · FY2001 · HL
CYCLOPHILIN C FUNCTION$115,911
K08 · FY2000 · HL